Jiangqin Zhao

Summary

Affiliation: Food and Drug Administration
Country: USA

Publications

  1. ncbi Rapid detection and differentiation of swine-origin influenza A virus (H1N1/2009) from other seasonal influenza A viruses
    Jiangqin Zhao
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Viruses 4:3012-9. 2012
  2. ncbi Multiplexed, rapid detection of H5N1 using a PCR-free nanoparticle-based genomic microarray assay
    Jiangqin Zhao
    Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    BMC Biotechnol 10:74. 2010
  3. ncbi CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon
    Jiangqin Zhao
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, 8800 RockvillePike, Bethesda, MD 20892, USA
    J Acquir Immune Defic Syndr 60:344-50. 2012
  4. ncbi Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection
    Shixing Tang
    Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, USA
    Clin Vaccine Immunol 17:1244-51. 2010
  5. ncbi HIV-1 and HIV-2 infections induce autophagy in Jurkat and CD4+ T cells
    Xue Wang
    Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, United States
    Cell Signal 24:1414-9. 2012
  6. ncbi Absence of detectable XMRV and other MLV-related viruses in healthy blood donors in the United States
    Shixing Tang
    Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America
    PLoS ONE 6:e27391. 2011
  7. ncbi Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon
    Viswanath Ragupathy
    Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Virol J 8:185. 2011
  8. ncbi Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon
    Jiangqin Zhao
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA
    AIDS Res Hum Retroviruses 26:1033-45. 2010
  9. ncbi Changes in the level of apoptosis-related proteins in Jurkat cells infected with HIV-1 versus HIV-2
    Xue Wang
    Labaratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Mol Cell Biochem 337:175-83. 2010
  10. ncbi c-FLIPL regulates PKC via AP-2 to inhibit Bax-mediated apoptosis induced by HIV-1 gp120 in Jurkat cells
    Xue Wang
    Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Building 29B, Rm 4NN16, 8800 Rockville Pike, Bethesda, MD, 20892, USA
    Mol Cell Biochem 330:23-9. 2009

Detail Information

Publications16

  1. ncbi Rapid detection and differentiation of swine-origin influenza A virus (H1N1/2009) from other seasonal influenza A viruses
    Jiangqin Zhao
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Viruses 4:3012-9. 2012
    ..This new method may be useful for simultaneous detection and subtyping of influenza A viruses and can be rapidly modified to detect other emerging influenza strains in public health settings...
  2. ncbi Multiplexed, rapid detection of H5N1 using a PCR-free nanoparticle-based genomic microarray assay
    Jiangqin Zhao
    Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    BMC Biotechnol 10:74. 2010
    ....
  3. ncbi CRF22_01A1 is involved in the emergence of new HIV-1 recombinants in Cameroon
    Jiangqin Zhao
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, 8800 RockvillePike, Bethesda, MD 20892, USA
    J Acquir Immune Defic Syndr 60:344-50. 2012
    ..Our studies show that novel recombinants between CRF22_01A1 and other clades and recombinant forms may be emerging in Cameroon that could contribute to the future global diversity of HIV-1 in this region and worldwide...
  4. ncbi Characterization of immune responses to capsid protein p24 of human immunodeficiency virus type 1 and implications for detection
    Shixing Tang
    Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, 8800 Rockville Pike, Bethesda, MD 20892, USA
    Clin Vaccine Immunol 17:1244-51. 2010
    ..The data provide the foundation for development and refinement of new assays for improved p24 antigen testing as future tools for rapid and accurate diagnosis as part of early intervention strategies and estimations of incidence...
  5. ncbi HIV-1 and HIV-2 infections induce autophagy in Jurkat and CD4+ T cells
    Xue Wang
    Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, United States
    Cell Signal 24:1414-9. 2012
    ..The results indicate that HIV is able to induce the autophagic signaling pathway in HIV-infected host cells, which may be required for HIV infection-mediated apoptotic cell death...
  6. ncbi Absence of detectable XMRV and other MLV-related viruses in healthy blood donors in the United States
    Shixing Tang
    Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland, United States of America
    PLoS ONE 6:e27391. 2011
    ..S. These results imply that millions of persons in the U.S. may be carrying the nucleic acid sequences of XMRV and/or MLV-related viruses, which is a serious public health and blood safety concern...
  7. ncbi Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon
    Viswanath Ragupathy
    Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Virol J 8:185. 2011
    ..The goal of our study was to determine recent trends in virus evolution and emergence of drug resistance in blood donors and HIV positive patients...
  8. ncbi Identification and genetic characterization of a novel CRF22_01A1 recombinant form of HIV type 1 in Cameroon
    Jiangqin Zhao
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA
    AIDS Res Hum Retroviruses 26:1033-45. 2010
    ....
  9. ncbi Changes in the level of apoptosis-related proteins in Jurkat cells infected with HIV-1 versus HIV-2
    Xue Wang
    Labaratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Mol Cell Biochem 337:175-83. 2010
    ....
  10. ncbi c-FLIPL regulates PKC via AP-2 to inhibit Bax-mediated apoptosis induced by HIV-1 gp120 in Jurkat cells
    Xue Wang
    Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Building 29B, Rm 4NN16, 8800 Rockville Pike, Bethesda, MD, 20892, USA
    Mol Cell Biochem 330:23-9. 2009
    ..Collectively, these findings further corroborate the concept that gp120 plays an important role, via involvement of molecules such as c-FLIPL, in apoptotic cell death due to HIV-1 infection...
  11. ncbi Molecules from apoptotic pathways modulate HIV-1 replication in Jurkat cells
    Xue Wang
    Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    Biochem Biophys Res Commun 414:20-4. 2011
    ..We also discuss the effects of MAPK signaling pathways and apoptosis on HIV-1 replication...
  12. ncbi Absence of detectable xenotropic murine leukemia virus-related virus in plasma or peripheral blood mononuclear cells of human immunodeficiency virus Type 1-infected blood donors or individuals in Africa
    Shixing Tang
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA
    Transfusion 51:463-8. 2011
    ....
  13. ncbi Viremia associated with fatal outcomes in ferrets infected with avian H5N1 influenza virus
    Xue Wang
    Lab of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Food and Drug Administration, Bethesda, Maryland, USA
    PLoS ONE 5:e12099. 2010
    ..Our observations further substantiate pathogenicity of H5N1 and further indicate that viremia may be a bio-marker for fatal outcomes in H5N1 infection...
  14. ncbi Stability and infectivity of novel pandemic influenza A (H1N1) virus in blood-derived matrices under different storage conditions
    Xue Wang
    Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, CBER FDA, Bethesda, MD 20892, USA
    BMC Infect Dis 11:354. 2011
    ..Furthermore the effect of storage on virus stability and infectivity has not been well studied...
  15. ncbi Detection of anthrax toxin by an ultrasensitive immunoassay using europium nanoparticles
    Shixing Tang
    Laboratory of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, Maryland 20892, USA
    Clin Vaccine Immunol 16:408-13. 2009
    ..These results indicate that the universal labeling technology based on europium nanoparticles and its application may provide a rapid and sensitive testing platform for clinical diagnosis and laboratory research...
  16. ncbi Nanoparticle-Based biobarcode amplification assay (BCA) for sensitive and early detection of human immunodeficiency type 1 capsid (p24) antigen
    Shixing Tang
    Lab of Molecular Virology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892, USA
    J Acquir Immune Defic Syndr 46:231-7. 2007
    ....